MapLight Therapeutics, Inc. MPLT Net unrealized gains (losses) on securities still held
Net unrealized gains (losses) on securities still held at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax.
The official record: MapLight Therapeutics, Inc. ’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about MapLight Therapeutics, Inc. 's net unrealized gains (losses) on securities still held.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MapLight Therapeutics, Inc. 's net unrealized gains (losses) on securities still held?
- MapLight Therapeutics, Inc. (MPLT) reported net unrealized gains (losses) on securities still held of -$655K in Q1 2026.
- How has MapLight Therapeutics, Inc. 's net unrealized gains (losses) on securities still held changed year-over-year?
- MapLight Therapeutics, Inc. 's net unrealized gains (losses) on securities still held decreased by 739.7% year-over-year, from -$78K to -$655K.
- What does net unrealized gains (losses) on securities still held mean?
- This metric captures the change in the fair value of investment securities held by the company that have not yet been sold. It represents unrealized gains or losses that are excluded from net income and instead reported within other comprehensive income. Monitoring this helps investors understand the volatility and market-driven fluctuations in the value of the company's investment portfolio.